Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease

NCT00069316 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

NIH

Sponsor class

Conditions

West Nile Virus

Interventions

DRUG: Omr-IgG-am

Sponsor

National Institutes of Health Clinical Center (CC)